GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition.
- Published In:
- Frontiers in pharmacology, 8, 904 (2017)
- Authors:
- Zhou, Xiao-Ming, Wang, Gui-Liang, Wang, Xiao-Bo, Liu, Li, Zhang, Qin, Yin, Yan, Wang, Qiu-Yue, Kang, Jian, Hou, Gang
- Database ID:
- RPEP-03550
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03550APA
Zhou, Xiao-Ming; Wang, Gui-Liang; Wang, Xiao-Bo; Liu, Li; Zhang, Qin; Yin, Yan; Wang, Qiu-Yue; Kang, Jian; Hou, Gang. (2017). GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition.. Frontiers in pharmacology, 8, 904. https://doi.org/10.3389/fphar.2017.00904
MLA
Zhou, Xiao-Ming, et al. "GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition.." Frontiers in pharmacology, 2017. https://doi.org/10.3389/fphar.2017.00904
RethinkPeptides
RethinkPeptides Research Database. "GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in..." RPEP-03550. Retrieved from https://rethinkpeptides.com/research/zhou-2017-ghk-peptide-inhibits-bleomycininduced
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.